Pancreatic Cyst Follow-up study
- Conditions
- Pancreatic cystsFollow-upPancreatic cystic neoplasms
- Registration Number
- NL-OMON27080
- Lead Sponsor
- Erasmus University Medical Center in Rotterdam, The Netherlands
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 5000
Inclusion Criteria
• Individuals with a pancreatic cyst (either newly or previously diagnosed)
• Cyst surveillance is warranted, according to the treating physician
Exclusion Criteria
• History of chronic pancreatitis
• Suspected pseudocyst
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcomes are: the number of patients that reach an indication for surgical cyst resection and the number of patients diagnosed with a malignant cyst (either high-grade dysplasia or carcinoma).
- Secondary Outcome Measures
Name Time Method Secondary outcomes are: <br /><br>1. the outcome of patients with an indication for cyst resection; i.e. the number of operated patients, surgical procedures, morbidity, mortality, and cyst recurrence <br /><br>2. cyst evolution, in terms of development of symptoms, cyst growth, nodules, and secondary pancreatic duct dilatation<br /><br>3. the perceived burden of surveillance on participants. <br /><br>4. possible risk factors for malignancy, either patient or cyst related<br /><br>5. to build a micro-simulation screening analysis (MISCAN) model, based on the outcome data of this study, in order to determine the optimal strategy for pancreatic cyst surveillance.